BUY Sai Life Sciences — Shrikant Chouhan, Kotak Securities
byShrikant Chouhan, Kotak SecuritiesHorizon: NA (inferred Swing (≤2wk))16 Sept 2026via ET Now (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days
Advisor consensus · same horizon·25 Sept · 4d ago
Sai Life Sciences' CRDMO Growth Is Expanding Beyond China-Plus-One
NewsNdtv-Profit·21 Sept · 1w ago
Contract Research Stock Up 89% in 1 Year: Why It Rallied
NewsGoogle News·10 Sept · 3w ago
Sai Life Sciences shares gain 5% to hit fresh record high
NewsCnbc-Tv18·8 Sept · 3w ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Sai Life Sciences
- BUY — Kunal Hasmukhlal Shah6 Nov 2026 · ~2 weeks · target ₹1,700 · Target hit
- BUY — MarketSmith India2 Nov 2026 · ~3 months · target ₹1,790 · Target hit
- BUY — Rajesh Satpute30 Oct 2026 · ~2 weeks · target ₹1,590 · Active
- BUY — Rajesh Satpute30 Oct 2026 · Same day · target ₹1,550 · Target hit
- BUY — Shrikant Chouhan, Kotak Securities30 Oct 2026 · ~2 weeks · target ₹1,575 · Target hit
More from Shrikant Chouhan, Kotak Securities
- BUY State Bank of India6 Nov 2026 · Same day · target ₹1,030 · Expired
- BUY Piramal Pharma6 Nov 2026 · ~2 weeks · target ₹250 · Active
- BUY Union Bank of India5 Nov 2026 · Next day · target ₹205 · Active
- BUY Maruti Suzuki India5 Nov 2026 · ~2 weeks · target ₹12,500 · Target hit
- BUY Dr. Lal Path Labs5 Nov 2026 · ~2 weeks · target ₹2,150 · SL hit